Canaccord Genuity Downgrades bluebird bio (BLUE) to Hold
Tweet
Share
E-mailGet Alerts BLUE Hot Sheet
Price: $4.97 --0%
Rating Summary:
10 Buy, 19 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 18 | Down: 12 | New: 24
Rating Summary:
10 Buy, 19 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 18 | Down: 12 | New: 24
Join SI Premium – FREE
Canaccord Genuity analyst John Newman downgraded bluebird bio (NASDAQ: BLUE) from Buy to Hold with a price target of $20.00.
For an analyst ratings summary and ratings history on bluebird bio click here. For more ratings news on bluebird bio click here.
Shares of bluebird bio closed at $18.16 yesterday.
You May Also Be Interested In
- Fox Advisors Downgrades Seagate Technology (STX) to Equalweight
- Berenberg Downgrades Umicore SA (UMI:BB) (UMICY) to Hold
- Citi Downgrades Sabra Healthcare REIT Inc. (SBRA) to Neutral
Create E-mail Alert Related Categories
DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
